Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 07.01.2022, 8.00 AMManagers' transactionsViking Line Abp has on January 6:th, 2022 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from a person closely associated with a person discharging managerial responsibilities in Viking Line Abp.Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Maelir ABPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In

Ranking The Top 10 Best Emotional Support Animal Letter Services of 2022

Emotional support animals (ESA's) are assistance animals that are extremely important for people's mental health and emotional well-being. But to be able to have an emotional support animal and be protected by and under federal law, you must get an ESA letter. So to help all that are in need of an emotional support animal right away, I ranked the top 10 best ESA letter services to have in 2022. Just to give you a heads-up, though, I'm gonna be telling you the #1 position so you can get a feel for what this article will be helping you for. The best emotional support

30 000 Lunette Cups to reach new customers in new channels

Peptonic Medical (publ) announced today that its wholly owned daughter company Lune Oy Ltd has signed a joint promotion agreement with American company Womanizer.A strategic partnership between Womanizer and Lunette - two businesses on a mission to end taboos around masturbation and menstrual health - will see 30,000 Lunette Menstrual Cups reach new customers in new channels in March 2022.  In a continuation of an already flourishing relationship between the brands, and to mark International Women’s Day on the March 8, every purchaser of the bestselling Womanizer Premium Vibrator will

SBB raises its forecast for the 2021 full year earnings per ordinary share A and B to SEK 13.70-14.20

Samhällsbyggnadsbolaget I Norden AB (“SBB”) raises its forecast for the 2021 full year earnings per ordinary share A and B to SEK 13.70-14.20. The previous forecast amounted to SEK 9.80 per ordinary share A and B and was published in connection with the interim report for January-September 2021. The updated forecast is based on preliminary earnings improvements in mainly SBB’s three value add strategies. SBB’s year-end report for 2021 will be published on 23 February 2022 at 08.00 CET.

Techstep ASA - Primary insider notification

Giraff AS, a company owned 100% by primary insider CEO Børge Astrup, has on 6 January 2022 purchased 215,397 shares in Techstep ASA at a price of NOK 3.6743 per share. After this transaction Børge Astrup controls 393,793 shares in Techstep ASA. Please see the attached form for further information. For further information, please contact: Børge Astrup, CEO, Techstep ASA: +47 928 27 676Marius Drefvelin, CFO, Techstep ASA: +47 958 95 690 The information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian

Toyota, Everfuel and DRIVR signs agreement on scaling up hydrogen taxis

Herning, Denmark, 6 January, 2022 – Everfuel, DRIVR and Toyota enter agreement on expanding the market for fuel-cell taxis.  The parties announce a five-year collaboration agreement that will scale the current number of fuel-cell taxis in Copenhagen, Denmark. Currently, over 100 of Toyota’s hydrogen cars, Mirai, are driving the streets of Copenhagen, as taxis at the Danish taxicab carrier, DRIVR. The three companies have a joint ambition of reaching 500 Mirais in Copenhagen by the end of 2025, and more than 200 by the end of 2022, which will significantly contribute to the

ADDvise receives order worth USD 1.1 million

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Design Infinity LCC, a Dubai based pharmaceutical industry engineering, interior design and fit out contractor. The order is worth approximately USD 1.1 million and involves design, supply, and installation of a 1000 sqm cleanroom facility for pharmaceutical production by the Himalaya Drug Company based in United Arab Emirates. The cleanroom system is developed and manufactured by MRC Systems. Delivery of the order is planned to take place during Q2 2022.  For further information, please contact:Rikard

Mercell Holding - Resolution to increase the share capital following exercise of options

Oslo, 6 January 2022: The board of directors of Mercell Holding ASA (the "Company" or "Mercell") has in a board meeting held today, on 6 January 2022, resolved to increase the Company's share capital with NOK 25,467.20 by the issuance of 127,336 new shares, each with a nominal value of NOK 0.20, in order to facilitate the exercise of 127,336 options under the Company's share option program. The exercise price per new share under the terms of the share option program is NOK 1.50. The board of directors' resolution to increase the share capital of the Company was made pursuant to the

Norway Royal Salmon (NRS): Q4-21 Trading update

Harvested volumes for the fourth quarter 2021 were 13.2 thousand tonnes gutted weight (tgw). This brings the total harvested volume for the full year up to 49.6 thousand tonnes gutted weight. Distributed to the below segments:                                Q4-2021                                           FY 2021 Farming Norway        : 10.3 thousand tgw                           38.1 thousand tgw Farming Iceland         :   2.9 thousand tgw                           11.5 thousand tgw The full Q4 2021 report will be released on 23 February 2022 at 06:30 CET. For further

CS MEDICA recruits 4 new employees to strengthen the sales department

CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the Company has hired four persons to strengthen the sales department. Until now, the Company has mainly been characterized as an early-staged R&D-centric development company. CS MEDICA will now focus on improving enterprise sales and establishing an enterprise-ready sales organization to grow further and penetrate new markets.With the intention to become more sales-focused, CS MEDICA has strengthened the team by hiring an additional four persons. The Company is currently in the process of transforming from mainly being an R&

Gain on divestment of Oslo Areal

Reference is made to the stock exchange release published on 3 December 2021 regarding the sale of Oslo Areal. As mentioned in the release, Gjensidige Forsikring Group will receive proceeds of approximately NOK 6.8 billion and will record a gain of approximately NOK 2 billion. Due to accounting rules, Gjensidige Forsikring Group will record a value appreciation of NOK 0.3 billion on the property assets in the investment portfolio for the fourth quarter of 2021. The value appreciation will be included in the Group’s financial result from the investment portfolio. The remaining NOK 1.7

Medius recognized in the Gartner® Critical Capabilities for Procure-to-Pay Suites report

6 January 2022, Stockholm – Medius, the leading provider of cloud-based spend management solutions, has been recognized in the 2021 Gartner® Critical Capabilities for Procure-to-Pay Suites report [1], ranking 3[rd] for the Finance-Focused Use Case. Medius believes this achievement is attributed to their innovative product development, truly customer-centric approach, and the modern technology powering Medius solutions. Jim Lucier, CEO at Medius, said: “We’re delighted to have been recognized in Gartner Critical Capabilities for Procure-to-Pay Suites report. Our extensive background

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them in Penneo A/S

Company Announcement No. 1-2022Copenhagen, 6 January 2022 In accordance with the Market Abuse Regulation, Penneo must notify Finanstilsynet and publicly disclose transactions made by persons discharging managerial responsibilities and persons closely associated with them on trading of Penneo shares. Penneo hereby notify and submit the following transaction of shares in Penneo: Name: André Clément Holding ApSTitle: Legal person closely associated with André Clément (Chief Commercial Officer of Penneo)

Mandatory notification of trade

Reference is made to the stock exchange notification 5 January 20:06:49 of the successful purchase of shares in OKEA ASA (the “Company”) in connection with the Company’s incentive program. Copies of notification of each of the persons discharging managerial responsibilities (“PDMRs”) for their respective participation in the purchase are attached hereto. For further information, please contact: CFO, Birte Norheim, +47 952 93 321 About OKEA OKEA ASA is a leading mid-to-late-life operator on the Norwegian continental shelf (NCS) with a current target production of 18 000 - 19 000

3Shape Files US Patent Infringement Complaint Against Carestream Dental Related to Wireless Scanning, Shade Measurement, and Wand Functionality

Copenhagen, January 6, 2022 – 3Shape A/S today announced that it has filed a complaint against Carestream Dental LLC, asserting that Carestream intraoral scanners infringe 3Shape patents related to wireless scanning, tooth color shade measurement, and the use of the handheld scanner wand as a remote control. 3Shape has filed the complaint in the United States District Court for the Western District of Texas. The complaint seeks monetary damages as well as injunctive relief. Regarding the infringement complaint, Thomas Kirkbak, Head of Litigation & Compliance at 3Shape said, “3Shape

BERGENBIO APPOINTS ANDERS TULLGREN AS CHAIRMAN OF BOARD

Bergen, Norway, 6 January 2022 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, announces today the appointment of Anders Tullgren to succeed Sveinung Hole as Chairman of the Board of Directors, effective today. Sveinung Hole has been Chairman of the Board since March 2019 and will continue to serve as a Board Member. Anders Tullgren has over 35 years of global experience in both large pharmaceutical and small/mid-size biotech environments, with senior leadership roles in the United

BerGenBio ASA: Extraordinary General Meeting held

Bergen, Norway, 6 January 2022 – BerGenBio ASA (OSE:BGBIO) announces that an extraordinary general meeting in the Company was held on 6 January 2022.   All proposals were resolved as presented in the notice convening the extraordinary general meeting distributed on 16 December 2022, as further set out in the minutes from the extraordinary general meeting attached hereto and available at https://www.bergenbio.com/investors/general- meetings/        -Ends-   For further information, please contact:

Westpack’s management team partners with Adelis to continue its international expansion

Westpack, a European market leader in high quality custom made packaging solutions for the European jewelry, watch and eyewear market, has partnered with Adelis Equity Partners (“Adelis”) for its next growth phase. Management will hold a significant ownership together with Adelis.Westpack is a European market leader in high quality custom made packaging solutions for the European jewelry, watch and eyewear market. The company’s customers are small, medium and large brand companies, as well as online and physical retailers. Headquartered in Holstebro, Denmark, Westpack employs approx. 180

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 5 - 6 JANUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

BerGenBio - Mandatory notification of trade by Primary Insiders

Bergen, Norway, 6 January 2022 – BerGenBio ASA (OSE: BGBIO) (the “Company”), has been notified that Martin Olin, CEO and primary insider of BerGenBio ASA, has bought 8,000 shares in BerGenBio ASA at an average price of NOK 19.87 per share. After the transaction Mr. Olin holds 8,000 shares in BerGenBio ASA.   Please see the attached document for further details of the transaction. Contact:  ir@bergenbio.com Rune Skeie, CFO, BerGenBio ASA rune.skeie@bergenbio.com   This information is subject to the disclosure requirements pursuant to the EU Market Abuse Regulation (MAR)

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 5th January 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,873,005 shares.  Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Cessatech announces changes to the Board of Directors

Cessatech has appointed Rachel Curtis Gravesen as Observer to the Board of Directors with the intention that she will be proposed as a member of the Board of Directors at the Company’s Annual General Meeting, which is scheduled to be held on March 17, 2022. The appointment follows significant business progress over the last year and Ulla Buhl’s decision to resign as a member of the Board of Directors to focus on other activities.Rachel has over 25 years’ experience in leadership, business and communication, with multiple roles in investor relations and communications. Currently running her

Photocure to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference

Press Release – Oslo, Norway January 6, 2022, Photocure ASA (PHO:OSE): The Bladder Cancer Company focused on delivering transformative solutions to improve the lives of bladder cancer patients, announces that President and Chief Executive Officer, Dan Schneider and Chief Financial Officer, Erik Dahl are scheduled to present a corporate overview and participate in meetings with investors at the H.C. Wainwright BioConnect 2022 Virtual Conference to be held January 10-13, 2022.Presentation Details: · Investors may listen to the Photocure presentation online beginning on January 10 at 1:

There are no items matching the current filter
There are no more items matching the current filter
Back to top